Using the Multidimensional Prognostic Index (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons: results and final recommendations from the MPI_AGE European Project
- 1 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Aging Clinical and Experimental Research
- Vol. 32 (5), 861-868
- https://doi.org/10.1007/s40520-020-01516-0
Abstract
MPI_AGE is a European Union co-funded research project aimed to use the Multidimensional Prognostic Index (MPI), a validated Comprehensive Geriatric Assessment (CGA)-based prognostic tool, to develop predictive rules that guide clinical and management decisions in older people in different European countries. A series of international studies performed in different settings have shown that the MPI is useful to predict mortality and risk of hospitalization in community-dwelling older subjects at population level. Furthermore, studies performed in older people who underwent a CGA before admission to a nursing home or receiving homecare services showed that the MPI successfully identified groups of persons who could benefit, in terms of reduced mortality, of specific therapies such as statins in diabetes mellitus and coronary artery disease, anticoagulants in atrial fibrillation and antidementia drugs in cognitive decline. A prospective trial carried out in nine hospitals in Europe and Australia demonstrated that the MPI was able to predict not only in-hospital and long-term mortality, but also institutionalization, re-hospitalization and receiving homecare services during the one-year follow-up after hospital discharge. The project also explored the association between MPI and mortality in hospitalized older patients in need of complex procedures such as transcatheter aortic valve implantation or enteral tube feeding. Evidence from these studies has prompted the MPI_AGE Investigators to formulate recommendations for healthcare providers, policy makers and the general population which may help to improve the cost-effectiveness of appropriate health care interventions for older patients.Keywords
Funding Information
- Consumers, Health, Agriculture and Food Executive Agency
This publication has 42 references indexed in Scilit:
- Development and Validation of a Multidimensional Prognostic Index for Mortality Based on a Standardized Multidimensional Assessment Schedule (MPI-SVaMA) in Community-Dwelling Older SubjectsJournal of the American Medical Directors Association, 2013
- Comprehensive geriatric assessment in the hemodialysis elderly populationJournal of Nephrology, 2012
- Comparing the Prognostic Accuracy for All-Cause Mortality of Frailty Instruments: A Multicentre 1-Year Follow-Up in Hospitalized Older PatientsPLOS ONE, 2012
- Prognostic Indices for Older AdultsJama-Journal Of The American Medical Association, 2012
- The Central Role of Prognosis in Clinical Decision MakingJama-Journal Of The American Medical Association, 2012
- Predicting DeathJAMA Internal Medicine, 2011
- Multidimensional Prognostic Index Based on a Comprehensive Geriatric Assessment Predicts Short-Term Mortality in Older Patients With Heart FailureCirculation: Heart Failure, 2010
- The Comprehensive Geriatric Assessment and the multidimensional approach. A new look at the older patient with gastroenterological disordersBest Practice & Research Clinical Gastroenterology, 2009
- The Multidimensional Prognostic Index Predicts Short- and Long-Term Mortality in Hospitalized Geriatric Patients With PneumoniaThe Journals of Gerontology: Series A, 2009
- Development and Validation of a Multidimensional Prognostic Index for One-Year Mortality from Comprehensive Geriatric Assessment in Hospitalized Older PatientsRejuvenation Research, 2008